• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Stability challenge in perovskite solar cell technology

Bioengineer by Bioengineer
December 23, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Shenghao Wang, OIST

While solar cell technology is currently being used by many industrial and government entities, it remains prohibitively expensive to many individuals who would like to utilize it.. There is a need for cheaper, more efficient solar cells than the traditional silicon solar cells so that more people may have access to this technology. One of the current popular topics in photovoltaic technology research centers around the use of organic-inorganic halide perovskites as solar cells because of the high power conversion efficiency and the low-cost fabrication.

Perovskites are a type of crystalline material that can be formed using a wide variety of different chemical combinations. Of the many different perovskites formulations that can be used in solar cells, the methylammonium lead iodide perovskite (MAPbI3) has been the most widely studied. Solar cells made of this material have been able to reach efficiencies exceeding 20% and are cheaper to manufacture than silicon. However, their short lifespans have prevented them from becoming a viable silicon solar cell alternative. In order to help create better solar cells in the future, members of the Energy Materials and Surface Sciences Unit at the Okinawa Institute of Science and Technology Graduate University (OIST) have been investigating the cause of rapid degradation of these perovskite solar cells (PSCs).

Dr. Shenghao Wang, first author of the publication in Nature Energy, suggests that the degradation of MAPbI3 perovskites may not be a fixable issue. His research reveals that iodide-based perovskites will universally produce a gaseous form of iodine, I2, during operation, which in turn causes further degradation of perovskite. While many researchers have pointed to other sources, such as moisture, atmospheric oxygen and heat as the cause of MAPbI3 degradation, the fact that these solar cells continue to degrade even in the absence of these factors led Wang to believe that a property intrinsic to these PSCs was causing the breakdown of material.

"We found that these PSCs are self-exposed to I2 vapor at the onset of degradation, which led to accelerated decomposition of the MAPbI3 perovskite material into PbI2." Wang explained, "Because of the relatively high vapor pressure of I2, it can quickly permeate the rest of the perovskite material causing damage of the whole PSC.

This research does not rule out the probability of using perovskites in solar cells, however. Professor Yabing Qi, leader of the Energy Materials and Surface Sciences Unit and corresponding author of this work, expounds "our experimental results strongly suggest that it is necessary to develop new materials with a reduced concentration of iodine or a reinforced structure that can suppress iodine-induced degradation, in addition to desirable photovoltaic properties".

These researchers at OIST are continuing to investigate different types of perovskite materials in order to find more efficient, cost-effective, and long lifespan perovskite material suitable for use. Their ultimate goal is to make solar cells that are affordable, efficient and stable so that they will be more accessible to the general population. Hopefully, better, cheaper solar cells will entice more people to utilize this technology.

###

Media Contact

Kaoru Natori
[email protected]
@oistedu

http://www.oist.jp/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations

September 7, 2025

Crizotinib Does Not Enhance Disease-Free Survival in Resected Early-Stage ALK-Positive NSCLC

September 7, 2025

FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Chemotherapy in EGFR-Mutated Advanced NSCLC

September 7, 2025

Ivonescimab Combined with Chemotherapy Enhances Progression-Free Survival in EGFR-Positive NSCLC Patients After Third-Generation EGFR-TKI Treatment

September 7, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    55 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations

Crizotinib Does Not Enhance Disease-Free Survival in Resected Early-Stage ALK-Positive NSCLC

FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Chemotherapy in EGFR-Mutated Advanced NSCLC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.